Free Trial
Your $100 Credit Expires Tomorrow! Get MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Don't Miss Out
Claim MarketBeat All Access Sale Promotion

Kyle Rose Analyst Performance

Analyst at Canaccord Genuity Group

Kyle Rose is a stock analyst at Canaccord Genuity Group focused in the medical sector, covering 16 publicly traded companies. Over the past year, Kyle Rose has issued 2 stock ratings, including and buy recommendations. While full access to Kyle Rose's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kyle Rose's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
67 Last 10 Years
Buy Recommendations
75.38% 49 Buy Ratings
Companies Covered
16 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy75.4%49 ratings
Hold24.6%16 ratings
Sell0.0%0 ratings

Out of 65 total stock ratings issued by Kyle Rose at Canaccord Genuity Group, the majority (75.4%) have been Buy recommendations, followed by 24.6% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
62.5% of companies on NASDAQ
10 companies
NYSE
37.5% of companies on NYSE
6 companies

Kyle Rose, an analyst at Canaccord Genuity Group, currently covers 16 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
14 companies
87.5%
Manufacturing
2 companies
12.5%

Kyle Rose of Canaccord Genuity Group specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

IndustryPercentage
MED PRODUCTS
5 companies
31.3%
MED INSTRUMENTS
3 companies
18.8%
SURGICAL & MEDICAL INSTRUMENTS
2 companies
12.5%
MEDICAL INFO SYS
2 companies
12.5%
SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES
1 company
6.3%
MEDICAL SERVICES
1 company
6.3%
SURGICAL APPLIANCES & SUPPLIES
1 company
6.3%
INDUSTRIAL MEASUREMENT INSTRUMENTS & RELATED PRODUCTS
1 company
6.3%

Kyle Rose's Ratings History at Canaccord Genuity Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Stryker Corporation stock logo
SYK
Stryker
5/1/2026Lower Price Target$295.43$400.00Buy
Insulet Corporation stock logo
PODD
Insulet
2/18/2026Lower Price Target$258.07$435.00Buy
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
2/26/2025Reiterated Rating$29.01$27.00Hold
Insulet Corporation stock logo
PODD
Insulet
2/21/2025Boost Price Target$288.29$324.00Buy
Stryker Corporation stock logo
SYK
Stryker
1/29/2025Boost Price Target$394.92$435.00Buy
Paragon 28, Inc. stock logo
FNA
Paragon 28
1/29/2025Reiterated Rating$13.00Hold